BioWorld. Link to homepage.
BioWorld
BioWorld MedTech
BioWorld Asia
BioWorld Science
Data Snapshots
BioWorld
BioWorld MedTech
Infographics: Dynamic digital data analysis
Special reports
Aging
Alzheimer's disease
Artificial intelligence
Biosimilars
China CAR T
Coronavirus
Infographics: Dynamic digital data analysis
Israel
IVDs on the rise
Radiopharmaceuticals
Rise of obesity
Top Biopharma Trends of 2023
Top Med-tech Trends of 2023
Top Preclinical Trends of 2023
Premium reports
BioWorld Financings Reports
Disease Incidence & Prevalence Summaries
BioWorld. Link to homepage.
sign in
Sign Out
My Account
Subscribe
BioWorld - Wednesday, April 24, 2024
Home
»
Newsletters
» BioWorld Science
BioWorld Science
July 27, 2011
View Archived Issues
Merck & Co. reports novel P2X7 receptor antagonists
Read More
Combined 96-week data disclosed from ECHO and THRIVE trials of rilpivirine versus efavirenz
Read More
Phase IIb data reported from SPRING-1 and VIKING trials of dolutegravir in HIV-1-infected adults
Read More
Japanese team describes novel putative biomarker of cognitive impairment in Alzheimer's disease
Read More
Phase III AQUIRE trial demonstrates benefits of aliskiren fumarate
Read More
Scientists reveal new potential biomarker of Alzheimer's disease
Read More
Hutchison MediPharma patents new HGF receptor inhibitors
Read More
Novel HIV protease inhibitors prepared by Hetero Research Foundation
Read More
Scientists at Novartis disclose novel beta-secretase 1 inhibitors
Read More
New GPR119 receptor agonists described by Nippon Chemiphar
Read More
Novel tryptase beta inhibitors patented
Read More
Chelsea Therapeutics reports on phase II droxidopa study
Read More
VaxOnco to sponsor phase I trial of Mayo Clinic cancer vaccine
Read More
Sublinox approved in Canada
Read More
TH-302 and bevacizumab enter clinical trial in astrocytoma
Read More
Almirall submits MAA to EMA for aclidinium bromide
Read More
ExonHit advances clinical validation of EHT Dx14
Read More
FDA issues safety alert regarding use of linezolid and methylene blue
Read More
Bayer Yakuhin launches Kogenate FS with Bio-Set injection 2000 in Japan
Read More
Merck & Co. to acquire rights to intravenous vernakalant
Read More
GlaxoSmithKline reports promising data from phase III ENABLE-1 study
Read More
EMA accepts for review Vanda's MAA for oral iloperidone formulation
Read More
Impax Pharmaceuticals fully enrolls ASCEND-PD phase III trial of IPX-066
Read More
TM-400 receives FDA orphan drug status
Read More
Aastrom reaches agreement with FDA on phase III REVIVE-CLI trial
Read More